Selected research
Industry Research
Glycobiology & Glycomics Industry Research Report 2026
Market perspective
The global Glycobiology & Glycomics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glycobiology & Glycomics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glycobiology & Glycomics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glycobiology & Glycomics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glycobiology & Glycomics include Waters Corp, Thermo Fisher Scientific, Shimadzu Corp, Danaher Corp, Takara Bio, Sigma-Aldrich Corp, Prozyme, New England Biolabs and Bruker Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glycobiology & Glycomics market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycobiology & Glycomics Market by Company
Waters Corp
Thermo Fisher Scientific
Shimadzu Corp
Danaher Corp
Takara Bio
Sigma-Aldrich Corp
Prozyme
New England Biolabs
Bruker Corp
Agilent Technologies
Glycobiology & Glycomics Segment by Type
Instruments
Kits
Enzymes
Eagents
Glycobiology & Glycomics Segment by Application
Immunology
Drug Discovery and Development
Diagnostics
Oncology
Others
Glycobiology & Glycomics Segment by Region
North America
United States
Canada
Europe
v
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycobiology & Glycomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycobiology & Glycomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycobiology & Glycomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glycobiology & Glycomics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glycobiology & Glycomics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glycobiology & Glycomics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Kits
- Enzymes
- Eagents
Applications
- Immunology
- Drug Discovery and Development
- Diagnostics
- Oncology
- Others
Companies covered
- Waters Corp
- Thermo Fisher Scientific
- Shimadzu Corp
- Danaher Corp
- Takara Bio
- Sigma-Aldrich Corp
- Prozyme
- New England Biolabs
- Bruker Corp
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glycobiology & Glycomics Market Size (2021-2032)
- 2.2.2 Global Glycobiology & Glycomics Sales (2021-2032)
- 2.2.3 Global Glycobiology & Glycomics Market Average Price (2021-2032)
- 2.3 Glycobiology & Glycomics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Instruments
- 2.3.3 Kits
- 2.3.4 Enzymes
- 2.3.5 Eagents
- 2.4 Glycobiology & Glycomics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunology
- 2.4.3 Drug Discovery and Development
- 2.4.4 Diagnostics
- 2.4.5 Oncology
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glycobiology & Glycomics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glycobiology & Glycomics Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Glycobiology & Glycomics Revenue of Manufacturers (2021-2026)
- 3.4 Global Glycobiology & Glycomics Average Price by Manufacturers (2021-2026)
- 3.5 Global Glycobiology & Glycomics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glycobiology & Glycomics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glycobiology & Glycomics, Product Type & Application
- 3.8 Global Manufacturers of Glycobiology & Glycomics, Established Date
- 3.9 Global Glycobiology & Glycomics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Waters Corp
- 4.1.1 Waters Corp Company Information
- 4.1.2 Waters Corp Business Overview
- 4.1.3 Waters Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Waters Corp Glycobiology & Glycomics Product Portfolio
- 4.1.5 Waters Corp Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Glycobiology & Glycomics Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Shimadzu Corp
- 4.3.1 Shimadzu Corp Company Information
- 4.3.2 Shimadzu Corp Business Overview
- 4.3.3 Shimadzu Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shimadzu Corp Glycobiology & Glycomics Product Portfolio
- 4.3.5 Shimadzu Corp Recent Developments
- 4.4 Danaher Corp
- 4.4.1 Danaher Corp Company Information
- 4.4.2 Danaher Corp Business Overview
- 4.4.3 Danaher Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Danaher Corp Glycobiology & Glycomics Product Portfolio
- 4.4.5 Danaher Corp Recent Developments
- 4.5 Takara Bio
- 4.5.1 Takara Bio Company Information
- 4.5.2 Takara Bio Business Overview
- 4.5.3 Takara Bio Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Takara Bio Glycobiology & Glycomics Product Portfolio
- 4.5.5 Takara Bio Recent Developments
- 4.6 Sigma-Aldrich Corp
- 4.6.1 Sigma-Aldrich Corp Company Information
- 4.6.2 Sigma-Aldrich Corp Business Overview
- 4.6.3 Sigma-Aldrich Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sigma-Aldrich Corp Glycobiology & Glycomics Product Portfolio
- 4.6.5 Sigma-Aldrich Corp Recent Developments
- 4.7 Prozyme
- 4.7.1 Prozyme Company Information
- 4.7.2 Prozyme Business Overview
- 4.7.3 Prozyme Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Prozyme Glycobiology & Glycomics Product Portfolio
- 4.7.5 Prozyme Recent Developments
- 4.8 New England Biolabs
- 4.8.1 New England Biolabs Company Information
- 4.8.2 New England Biolabs Business Overview
- 4.8.3 New England Biolabs Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 New England Biolabs Glycobiology & Glycomics Product Portfolio
- 4.8.5 New England Biolabs Recent Developments
- 4.9 Bruker Corp
- 4.9.1 Bruker Corp Company Information
- 4.9.2 Bruker Corp Business Overview
- 4.9.3 Bruker Corp Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bruker Corp Glycobiology & Glycomics Product Portfolio
- 4.9.5 Bruker Corp Recent Developments
- 4.10 Agilent Technologies
- 4.10.1 Agilent Technologies Company Information
- 4.10.2 Agilent Technologies Business Overview
- 4.10.3 Agilent Technologies Glycobiology & Glycomics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Agilent Technologies Glycobiology & Glycomics Product Portfolio
- 4.10.5 Agilent Technologies Recent Developments
5 Global Glycobiology & Glycomics Market Scenario by Region
- 5.1 Global Glycobiology & Glycomics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glycobiology & Glycomics Sales by Region: 2021-2032
- 5.2.1 Global Glycobiology & Glycomics Sales by Region: 2021-2026
- 5.2.2 Global Glycobiology & Glycomics Sales by Region: 2027-2032
- 5.3 Global Glycobiology & Glycomics Revenue by Region: 2021-2032
- 5.3.1 Global Glycobiology & Glycomics Revenue by Region: 2021-2026
- 5.3.2 Global Glycobiology & Glycomics Revenue by Region: 2027-2032
- 5.4 North America Glycobiology & Glycomics Market Facts & Figures by Country
- 5.4.1 North America Glycobiology & Glycomics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glycobiology & Glycomics Sales by Country (2021-2032)
- 5.4.3 North America Glycobiology & Glycomics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Glycobiology & Glycomics Market Facts & Figures by Country
- 5.5.1 Europe Glycobiology & Glycomics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glycobiology & Glycomics Sales by Country (2021-2032)
- 5.5.3 Europe Glycobiology & Glycomics Revenue by Country (2021-2032)
- 5.5.4 v
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Glycobiology & Glycomics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glycobiology & Glycomics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glycobiology & Glycomics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glycobiology & Glycomics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glycobiology & Glycomics Market Facts & Figures by Country
- 5.7.1 South America Glycobiology & Glycomics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glycobiology & Glycomics Sales by Country (2021-2032)
- 5.7.3 South America Glycobiology & Glycomics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Glycobiology & Glycomics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glycobiology & Glycomics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glycobiology & Glycomics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glycobiology & Glycomics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Glycobiology & Glycomics Sales by Type (2021-2032)
- 6.1.1 Global Glycobiology & Glycomics Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Glycobiology & Glycomics Sales Market Share by Type (2021-2032)
- 6.2 Global Glycobiology & Glycomics Revenue by Type (2021-2032)
- 6.2.1 Global Glycobiology & Glycomics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glycobiology & Glycomics Revenue Market Share by Type (2021-2032)
- 6.3 Global Glycobiology & Glycomics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glycobiology & Glycomics Sales by Application (2021-2032)
- 7.1.1 Global Glycobiology & Glycomics Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Glycobiology & Glycomics Sales Market Share by Application (2021-2032)
- 7.2 Global Glycobiology & Glycomics Revenue by Application (2021-2032)
- 7.2.1 Global Glycobiology & Glycomics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glycobiology & Glycomics Revenue Market Share by Application (2021-2032)
- 7.3 Global Glycobiology & Glycomics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glycobiology & Glycomics Value Chain Analysis
- 8.1.1 Glycobiology & Glycomics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glycobiology & Glycomics Production Mode & Process
- 8.2 Glycobiology & Glycomics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glycobiology & Glycomics Distributors
- 8.2.3 Glycobiology & Glycomics Customers
9 Global Glycobiology & Glycomics Analyzing Market Dynamics
- 9.1 Glycobiology & Glycomics Industry Trends
- 9.2 Glycobiology & Glycomics Industry Drivers
- 9.3 Glycobiology & Glycomics Industry Opportunities and Challenges
- 9.4 Glycobiology & Glycomics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst